ATE195428T1 - Arznei für rheumatoide arthritis - Google Patents

Arznei für rheumatoide arthritis

Info

Publication number
ATE195428T1
ATE195428T1 AT95913319T AT95913319T ATE195428T1 AT E195428 T1 ATE195428 T1 AT E195428T1 AT 95913319 T AT95913319 T AT 95913319T AT 95913319 T AT95913319 T AT 95913319T AT E195428 T1 ATE195428 T1 AT E195428T1
Authority
AT
Austria
Prior art keywords
rheumatoid arthritis
medicine
remedy
monoclonal antibody
antibody recognizing
Prior art date
Application number
AT95913319T
Other languages
English (en)
Inventor
Tadashi Nishida
Sachiko Miyake
Hideo Yagita
Ko Okumura
Original Assignee
Kanebo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanebo Ltd filed Critical Kanebo Ltd
Application granted granted Critical
Publication of ATE195428T1 publication Critical patent/ATE195428T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2845—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2821—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against ICAM molecules, e.g. CD50, CD54, CD102
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2842—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta1-subunit-containing molecules, e.g. CD29, CD49
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2875—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF/TNF superfamily, e.g. CD70, CD95L, CD153, CD154
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT95913319T 1994-04-26 1995-03-22 Arznei für rheumatoide arthritis ATE195428T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8825194 1994-04-26
PCT/JP1995/000527 WO1995028961A1 (fr) 1994-04-26 1995-03-22 Medicament pour polyarthrite rhumatoide

Publications (1)

Publication Number Publication Date
ATE195428T1 true ATE195428T1 (de) 2000-09-15

Family

ID=13937651

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95913319T ATE195428T1 (de) 1994-04-26 1995-03-22 Arznei für rheumatoide arthritis

Country Status (9)

Country Link
US (1) US5855888A (de)
EP (1) EP0759302B1 (de)
AT (1) ATE195428T1 (de)
DE (1) DE69518415T2 (de)
DK (1) DK0759302T3 (de)
ES (1) ES2151054T3 (de)
GR (1) GR3034200T3 (de)
PT (1) PT759302E (de)
WO (1) WO1995028961A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69934420T2 (de) * 1998-10-07 2007-09-27 Lennart Lindbom Anti-entzündliche alpha2, beta1 integrin-verwandte substanzen oder antikörper
EE05662B1 (et) * 1999-04-22 2013-06-17 Biogen, Inc. Fibroosi ravimise kompositsioon, mis kasutab integriin alfa-4 subhiku antagonisti ja selle kompositsiooni kasutamine
DK2314315T3 (en) 1999-06-01 2015-02-02 Biogen Idec Inc Blocking monoclonal antibody to the human alpha1-I domain of VLA-1 and their use for the treatment of inflammatory diseases
US6146639A (en) * 1999-07-26 2000-11-14 Merich Nick Arthritis, muscle pain, and dry skin remedy
PL367324A1 (en) 2001-04-13 2005-02-21 Biogen, Inc. Antibodies to vla-1
US20030013107A1 (en) * 2001-06-07 2003-01-16 Rigel Pharmaceuticals, Incorporated Alpha 2 integrin: modulators of lymphocyte activation
CA2629715C (en) * 2005-11-18 2016-05-03 Glenmark Pharmaceuticals S.A. Anti-alpha2 integrin antibodies and their uses
EP2839843B1 (de) * 2006-05-25 2018-06-20 Biogen MA Inc. VLA-1-Antagonisten zur Verwendung bei der Behandlung von Schlaganfall
US20080267978A1 (en) * 2006-08-28 2008-10-30 Mary Zutter Anti-angiogenic targets for cancer therapy
CA2840175C (en) * 2011-05-19 2021-11-16 The Regents Of The University Of Michigan Integrin alpha-2 binding agents and use thereof to inhibit cancer cell proliferation
US10316095B2 (en) 2012-02-16 2019-06-11 Santarus, Inc. Antibody formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0330506A3 (de) * 1988-02-26 1990-06-20 Dana Farber Cancer Institute VLA-Proteine
DK162890D0 (da) * 1990-07-06 1990-07-06 Novo Nordisk As Polypeptid
EP0605442B1 (de) * 1991-07-25 2003-04-16 Idec Pharmaceuticals Corporation Rekombinante antikörper zur humanen therapie

Also Published As

Publication number Publication date
EP0759302A4 (de) 1997-11-19
WO1995028961A1 (fr) 1995-11-02
ES2151054T3 (es) 2000-12-16
DE69518415T2 (de) 2001-01-25
DE69518415D1 (de) 2000-09-21
US5855888A (en) 1999-01-05
EP0759302B1 (de) 2000-08-16
GR3034200T3 (en) 2000-11-30
EP0759302A1 (de) 1997-02-26
PT759302E (pt) 2001-01-31
DK0759302T3 (da) 2000-11-13

Similar Documents

Publication Publication Date Title
DE69518415D1 (de) Arznei für rheumatoide arthritis
ITMI921522A0 (it) Apparato di lavaggio e sterilizzazione di tappi di gomma, o simili impiegabili in confezioni farmaceutiche
DE69530316D1 (de) Antithrombose mittel und gegen den von willebrand-faktor gerichtete monoklonale antikörper
ITMI910584A1 (it) Composizione farmaceutica idrofila contenente ketoprofene sale di lisina per uso topico.
FI932958A0 (fi) Elastisk paose foer att packa in sammantryckbara produkter, speciellt sanitetsartiklar saosom bloejor, samt en foerpackning i vilken sammantryckta sanitetsprodukter foerpackats
WO1994008551A3 (en) Pharmaceutical compositions and methods for treating cold symptoms
DE69635582D1 (de) Diagnostika und behandlungen von peridontalen erkrankungen
FI893159A (fi) Laite ja menetelmä terveydenhuollossa syntyvien ongelmajätteiden käsittelemiseksi
PL316449A1 (en) Combinations of thrombolytically active proteins and coagulants and their application
BR9406292A (pt) Complexo de inclusão de taxol ou taxotere ou extrato de taxus formados com ciclodextrinas sua preparação e uso
DE60116302D1 (de) Behandlung von seborrhoischer dermatitis
FR2656214B1 (fr) Cadre dynamique d'osteosynthese du rachis.
ATE433339T1 (de) Parasympathikomimetikum und parasympathikolytikum enthaltendes tts
DK0556322T3 (da) Aminosulfonylurinstof-ACAT-inhibitorer
DE69613168T2 (de) Verwendung eines CGRP-Antagonisten zur Behandlung von Lichen und Pruritus und erhaltene Zusammensetzung
ES2133304T3 (es) Composiciones oftalmicas que comprenden combinaciones de un inhibidor de la anhidrasa carbonica y un antagonista beta-adrenergico.
SE9404331L (sv) Förfarande för sträckning av en materialbana vid framställning av vätskeabsorberande alster och anordning för materialbanans sträckning
DK0471718T3 (da) Paracetamolholdigt farmaceutisk præparat
ES2187618T3 (es) Utilizacion de compuestos de urea y de tiourea para la eliminacion o desintoxicacion de superantigenos de fluidos corporales.
ATE195055T1 (de) Insektizide zusammensetzung die diatomeenerde und siliziumdioxid enthalten
ATE107165T1 (de) Verwendung von macrolactonen als antiallergica.
DE69230644T2 (de) Verwendung von protease nexin-i als mittel gegen entzündungen
IT8819650A0 (it) Apparecchio per la ginnastica attiva del viso e del collo.
KR950701812A (ko) 렌티바이러스-유도된 질환의 치료에 유용한 생물학적으로 활성인 우레이도 유도체(Biologically active ureido dervatives useful in the treatment of lentivirus-induced sisease)
FR2690330B1 (fr) Dispositif destine a traiter certaines fractures siegeant entre massif trochanterien et 1/3 moyen de la diaphyse femorale.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee